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Abstract
Background: The genetic basis of hearing loss in humans is relatively poorly understood. In recent years,
experimental approaches including laboratory studies of early onset hearing loss in inbred mouse strains, or
proteomic analyses of hair cells or hair bundles, have suggested new candidate molecules involved in hearing
function. However, the relevance of these genes/gene products to hearing function in humans remains unknown.
We investigated whether single nucleotide polymorphisms (SNPs) in the human orthologues of genes of interest
arising from the above-mentioned studies correlate with hearing function in children.
Methods: 577 SNPs from 13 genes were each analysed by linear regression against averaged high (3, 4 and 8 kHz)
or low frequency (0.5, 1 and 2 kHz) audiometry data from 4970 children in the Avon Longitudinal Study of Parents
and Children (ALSPAC) birth-cohort at age eleven years. Genes found to contain SNPs with low p-values were then
investigated in 3417 adults in the G-EAR study of hearing.
Results: Genotypic data were available in ALSPAC for a total of 577 SNPs from 13 genes of interest. Two SNPs
approached sample-wide significance (pre-specified at p = 0.00014): rs12959910 in CBP80/20-dependent translation
initiation factor (CTIF) for averaged high frequency hearing (p = 0.00079, β = 0.61 dB per minor allele); and
rs10492452 in L-plastin (LCP1) for averaged low frequency hearing (p = 0.00056, β = 0.45 dB). For low frequencies,
rs9567638 in LCP1 also enhanced hearing in females (p = 0.0011, β = −1.76 dB; males p = 0.23, β = 0.61 dB,
likelihood-ratio test p = 0.006). SNPs in LCP1 and CTIF were then examined against low and high frequency
hearing data for adults in G-EAR. Although the ALSPAC results were not replicated, a SNP in LCP1, rs17601960, is
in strong LD with rs9967638, and was associated with enhanced low frequency hearing in adult females in G-EAR
(p = 0.00084).
Conclusions: There was evidence to suggest that multiple SNPs in CTIF may contribute a small detrimental
effect to hearing, and that a sex-specific locus in LCP1 is protective of hearing. No individual SNPs reached
sample-wide significance in both ALSPAC and G-EAR. This is the first report of a possible association between
LCP1 and hearing function.
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Background
Hearing impairment has a major impact on quality of
life. The difficulties associated with progressive hearing
loss are particularly apparent with regard to the growing
population of older individuals [1, 2]. Nevertheless, even
minimal hearing loss in school-age children, which can
be detected in around 1 % of children [3], may affect
performance at school [4]. It is recognised that progres-
sive hearing loss relates to both genetic and environ-
mental factors, and to the interaction between these
factors [5, 6]. Greater knowledge of the genetic factors
that contribute to hearing loss could assist early identifi-
cation of susceptible individuals in the general
population.
Over the last 10–15 years, major advances have been
made in understanding the molecular basis of mechano-
transduction of sound waves in the mammalian inner
ear, largely from the study of inherited forms of deafness
[7, 8]. In the inner ear, the auditory epithelium contains
specialised hair cells with an elaborate morphology in
which the apical surfaces are decorated with stereociliary
or “hair” bundles. These make contact with the tectorial
membrane, which is deflected by incoming sound waves.
Each bundle is composed of a group of stereocilia, orga-
nised spatially such that they increase in length across
the bundle. A protein complex, the tip link complex, is
located at the tip of each stereocilium and makes contact
with adjacent stereocilia such that the bundle is dis-
placed in a coordinated way upon deflection of the
tectorial membrane [7]. Each stereocilium is made rigid
by a central bundle of cross-linked actin microfilaments
(F-actin) that contains fascin-2 and other actin-binding
proteins [7, 9]. Myosins and an intracellular protein
complex provide linkage between the tip complex and
the F-actin bundle. Movements of the stereocilia activate
an as yet unknown mechanotransducer channel and Ca2+
ion movements; in inner ear hair cells this initiates intra-
cellular signals and second messengers that activate im-
pulses in adjacent nerve cells [7]. Mutations in multiple
components of the tip link complex, for example,
cadherin-23, are causal for the deafness/blindness syn-
drome, Usher syndrome type I [7, 8, 10–12].
A less-utilised route towards the identification of gen-
etic factors associated with hearing in humans is to build
on recent studies of the proteome of hair cells and new
identifications of hearing-associated genes in inbred
strains of laboratory mice [13–15]. The proteomic stud-
ies in several species have revealed more comprehen-
sively the complexity of inner ear cells and have
identified previously unsuspected protein components of
hair bundles [13]. Similarly, studies of early-onset hear-
ing loss in laboratory mice have implicated a number of
genes in hearing function for the first time [13, 15]. The
relevance of many of these gene products or their
encoding genes to human hearing function remains
unclear. Furthermore, to our knowledge, genomic asso-
ciation studies of hearing function in humans, to date,
have examined only adult populations.
In this study, we selected a suite of genes on the basis
of recent published experimental evidence of localisation
of their transcripts or protein products in hair cells, or
new functional data that associate these genes with hear-
ing function in mice [13–15]. To examine whether single
nucleotide polymorphisms (SNPs) in the selected genes
are associated with variation in hearing function in chil-
dren at age 11 years, we analysed the large Avon Longi-
tudinal Study of Parents and Children (ALSPAC) birth
cohort [16] for possible associations. The results were
further examined and validated with reference to a study
of hearing function in European adults from isolated
villages that was conducted within the international
G-EAR consortium [17].
Methods
ALSPAC is a population-based prospective cohort study
investigating factors that affect the health and develop-
ment of children and their parents. The study methods
are described in detail elsewhere [16, 18]. The study
website contains details of all the data that is available
through a searchable data dictionary http://www.bris.
ac.uk/alspac/researchers/data-access/data-dictionary/. In
brief, 14, 541 women who had an expected delivery date
between April 1991 and December 1992 were enrolled
in the study. 13,988 live born infants survived to at least
one year of age. Children eligible for inclusion in our
analysis had at least one audiometry test at 11 years of
age (n = 7082); were of white ethnicity (n = 6212); and
had DNA genotyping data available (n = 4970). The
ALSPAC children have been genotyped previously using
the Illumina HumanHap550 quad chip (Illumina Inc.,
San Diego, CA) according to the stated protocol [19].
SNPs with a minor allele frequency of < 1 % or a call rate
of < 95 % were removed from the dataset. Ethical ap-
proval for the study was obtained from the ALSPAC
Ethics and Law Committee and the Local Research
Ethics Committees.
Genes of interest were identified on the basis of recent
studies of hair cell or hair bundle proteomics and/or
studies of early-onset hearing loss in inbred strains of
laboratory mice [13–15] and genotyping data for all
SNPs listed in these genes in NCBI dbSNP [20] were re-
quested from ALSPAC. Information on SNPs was avail-
able for thirteen genes of interest (Table 1, which also
indicates the rationale for including each gene in the
analysis). CHD23 and PCDH15 were included in the set
because of their known roles in inherited forms of deaf-
ness [11, 12, 21]. SNPs that had been genotyped within
ALSPAC were made available in anonymised form
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(ALSPAC service level agreement B1480). Genotypic
dosage for all SNPs of interest, which represents the
expected number of the rare (SNP) allele in the range
from 0 to 2 (where 0 is the most common allele and 2
represents homozygous for the rare allele), was used in
the association analysis. Genotypes were checked for
deviation from the Hardy-Weinberg equilibrium using
the hwsnp function implemented in Stata (StataCorp
LP, 2012, College Station, TX). Any SNP with evi-
dence of violations of Hardy-Weinberg equilibrium
(p < 8.65×10−5), >5 % missing, or incorrect imputations,
(as defined by a genotypic dosage more than 0.05 away
from 0, 1 or 2), was discarded.
Population stratification
The top 10 principal components (PCs) that reflect the
genetic structure of the population were estimated
according to Price et al. [22] from genome-wide SNPs
genotyped, imputed and cleaned in ALSPAC children, as
described above. All 10 PCs were included as covariates
in the regression models to account for confounding by
population stratification.
Measures of hearing function
Hearing function of the cohort was examined using air
conduction pure tone audiometry and an objective
measure of cochlear function, otoacoustic emissions
(OAE), at age 11 years. All tests were conducted by au-
diologists or trained physiology staff and measurements
were carried out as described in Hall et al., 2012 [23].
Hearing thresholds were measured in both ears at 0.5 –
8 kHz according to the British Society of Audiology
recommended procedure for audiometry [24]. For our
analysis, the lowest threshold for each frequency, i.e., the
ear with the best hearing, was used to create 2 new pure
tone averages (PTA) by taking the PTA of the high/
medium (3, 4 and 8 kHz) or the low/medium (0.5, 1 and
2 kHz) frequency hearing thresholds. This is standard
practice in epidemiological studies of hearing [25].
Transient evoked OAE were measured in both ears
and the OAE response level was measured from the un-
filtered recordings and at 1, 2, 3 and 4 kHz as described
in detail in Hall et al., 2012 [23]. In our analysis, to pre-
serve statistical power, the unfiltered (broadband) record-
ings were used. Large OAE amplitudes are associated with
better hearing function. The hearing levels of the ALSPAC
subjects are listed in Table 2.
Statistical methods
Haploview was used to calculate the number of LD
blocks in the SNPs studied, using the solid spine of LD
option [26]. A Bonferroni correction was applied by
using the number of LD blocks across all the SNPs stud-
ied as an estimate of the number of independent tests in
the sample, because linkage disequilibrium in association
studies results in non-independent tests and an over-
correction for Type 1 errors [27]. This method of cor-
rection has been criticised as insufficiently conservative
for genome-wide association studies, but our study uses
a limited number of SNPs from a relatively small set of
genes [28].
Linear regression was used to determine if any of the
SNPs correlated with an effect on the high- or low-
frequency PTAs or the broadband OAE results, using
Table 1 Summary of the genes analysed in this study
Gene acronym Full gene name Known association of mutations with human audiological condition Reference
CDH23 Cadherin-23 Non-syndromic deafness, early-onset deafness [11, 12]
ESPNL Espin-like None reported; protein present in hair bundles (rat and chick) [13]
FSCN2 Fascin-2 None reported; Fscn2 mutation associated with early onset≤ 16 kHz
hearing loss in C57BL/6 J mice (ahl8); protein present in hair bundles
(rat, chick, zebrafish)
[8, 13, 32]
HCN2 hyperpolarization activated cyclic
nucleotide-gated potassium channel 2
None reported; expressed in cochlear hair cells (mouse, rat) [46, 47]
LCP1 Plastin-2/L-plastin None reported; protein present in hair bundles (chick) [13]
PDCH15 protocadherin-15 Non-syndromic deafness, Usher Syndrome type 1 F [6–8, 21]
XIRP2 xin actin-binding repeat containing 2 None reported; protein present in hair bundles (rat and chick) [13]
ACAA2 acetyl-CoA acyltransferase 2 None reported; ACAA2, c18orf32, CTIF, DYM, MYO5B and SMAD7 are
human orthologues of six genes in the ahl9 QTL on mouse
chromosome 18 that is associated with low frequency hearing
loss in BXD recombinant inbred mice by 2–3 months of age.
[15]
c18orf32 chromosome 18 open reading frame 32
CTIF CBP80/20-dependent translation
initiation factor
DYM dymeclin
MYO5B myosin VB
SMAD7 SMAD family member 7
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the 10 principal components as co-variables. The ana-
lyses were also stratified by gender, because evidence
from our validation study (see below) suggested that the
observed effects were gender specific. The a priori
threshold for significance to which the p-values were
compared was calculated as 0.05/([the number of fre-
quencies tested]*[the number of independent tests]);
however, it is noted that this may still be conservative
because the high and low frequency PTAs might be
associated, making them non-independent tests. All
Table 2 Summary of hearing threshold levels and otoacoustic emission amplitudes in ALSPAC children
Measure Frequency (kHz) Gender Number Mean (SD) Range (dB) N > 40 dB (%)
Audiometry 0.5 All 4931 2.93 (6.0) −10 to 80 12 (0.24)
1 All 4970 1.40 (6.0) −10 to 95 10 (0.20)
2 All 4969 1.38 (6.2) −10 to 110 10 (0.20)
3 All 4936 1.22 (6.3) −10 to 110 10 (0.20)
4 All 4964 1.07 (6.6) −10 to 100 10 (0.20)
8 All 4950 4.57 (8.0) −10 to 65 17 (0.34)
High frequency All 4923 2.27 (5.6) −10 to 70 7 (0.14)
Low frequency All 4931 1.90 (5.2) −10 to 95 10 (0.20)
OAE Broadband All 3711 13.78 (5.5) −9 to 31 -
1 All 3711 8.36 (7.0) −13 to 26 -
2 All 3711 6.90 (6.6) −17 to 28 -
3 All 3711 4.21 (7.2) −17 to 28 -
4 All 3711 0.35 (7.3) −21 to 24 -
Audiometry 0.5 Males 2421 2.96 (5.8) −10 to 60 5 (0.21)
1 Males 2445 1.55 (5.8) −10 to 65 4 (0.16)
2 Males 2444 1.49 (6.0) −10 to 70 3 (0.12)
3 Males 2426 1.57 (6.0) −10 to 75 4 (0.16)
4 Males 2441 1.20 (6.7) −10 to 75 5 (0.20)
8 Males 2436 5.01 (8.2) −10 to 65 9 (0.37)
High frequency Males 2421 2.59 (5.7) −10 to 70 3 (0.12)
Low frequency Males 2421 1.98 (5.0) −8 to 62 3 (0.12)
OAE Broadband Males 1848 12.90 (5.4) −9 to 31 -
1 Males 1848 7.56 (6.9) −13 to 26 -
2 Males 1848 5.87 (6.5) −17 to 25 -
3 Males 1848 3.00 (7.0) −17 to 28 -
4 Males 1848 −0.53 (7.1) −21 to 24 -
Audiometry 0.5 Females 2510 2.91 (6.2) −10 to 80 7 (0.28)
1 Females 2525 1.25 (6.2) −10 to 95 6 (0.24)
2 Females 2525 1.27 (6.3) −10 to 110 7 (0.28)
3 Females 2510 0.89 (6.6) −10 to 110 6 (0.24)
4 Females 2523 0.95 (6.5) −10 to 100 5 (0.20)
8 Females 2514 4.14 (7.8) −10 to 55 8 (0.32)
High frequency Females 2502 1.96 (5.5) −10 to 57 4 (0.16)
Low frequency Females 2510 1.82 (5.5) −10 to 95 7 (0.28)
OAE Broadband Females 1863 14.65 (5.5) −5 to 29 -
1 Females 1863 9.15 (6.9) −13 to 26 -
2 Females 1863 7.92 (6.5) −15 to 28 -
3 Females 1863 5.42 (7.3) −16 to 23 -
4 Females 1863 1.22 (7.4) −21 to 22 -
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analyses were carried out in Stata version 13 (StataCorp
LP, 2012, College Station, TX). In the reporting of the
effect sizes of the minor (SNP) alleles, a positive value
represents reduced hearing and a negative value repre-
sents enhanced hearing.
External validation and combination of data
The most interesting results from our analysis of 11-year
old children in ALSPAC were compared with an external
genome-wide association study (GWAS) G-EAR, on the
basis of the p-values and directions of effects. The full
G-EAR study is described elsewhere [17], briefly, 3417
subjects within G-EAR aged 18 years or older were
recruited from isolated villages in Italy and Croatia and
underwent pure-tone audiometry, tympanometry, and
acoustic reflex testing in both ears after any acoustically
obstructing ear-wax had been removed. Analysis of hear-
ing function was undertaken by calculating the PTA of
air conduction using the best ear at the lower (0.25, 0.5,
and 1 kHz), medium (0.5, 1, and 2 kHz), and high fre-
quencies (4, 8 kHz). Each trait was regressed against age,
sex and genomic kinship prior to analysis. For our study,
the audiometry results in G-EAR were rank trans-
formed because the data were skewed, unlike the data
from ALSPAC which were approximately normally
distributed.
The rank transformation of the G-EAR data limited
the possible merging of results and comparison of effect
sizes: rank transformations rank the data smallest to lar-
gest and force each data point’s rank value to a normal
distribution with minimum value 0 and maximum value
1. Thus, the effect sizes in the G-EAR study related to
an artificially created normal curve, but they were con-
sistent with the ALSPAC study: i.e., positive effects imply
worse hearing function.
Genomic loci of SNPs
The position of SNPs of interest within CTIF and LCP1
was examined with reference to dbSNP at NCBI and by
BLASTN searches of the NCBI human genome GRCh38
primary assembly [29]. SNP positions were identified on
reference assembly annotation release 105 using the
table of reference sequence transcripts in the Map view
function. Diagrams of gene structure for LCP1 and CTIF
were prepared from exports from Ensembl 2014 [30],
(CTIF from entry ENSG00000134030 and LCP1 from
entry ENSG00000136167), and are presented in fancy-
GENE 1.4 [31].
Results
Identification of SNPs in CTIF and LCP1 that correlate with
altered hearing in ALSPAC children
For the 7082 children for whom hearing data had been
obtained at 11 years of age, 4970 (70.2 %) were of white
ethnicity and had full genotypic data. 49 % (n = 2445) of
the children were male. The data on hearing function
for the 4970 children are summarised in Table 2. Geno-
typic data were available for 602 SNPs from the 13 genes
of interest: 24 SNPs had >5 % incorrect imputations
(defined as being >0.05 away from a whole number,
where 0 was homozygous for the major allele, 1 was het-
erozygous and 2 was homozygous for the minor allele)
and were removed and 1 SNP was out of HW equilibrium
(no minor allele homozygotes), leaving a total of 577 SNPs
from 13 genes for our analysis (Table 3).
Haploview’s solid spine of LD computed 118 groups of
LD, which gave a sample-wide SNP threshold p-value of
0.00014 [0.05/(3*118) = 0.00014]. The effect size (β) of
the regression represents the decibel (dB) change in the
hearing threshold for the averaged frequencies for each
copy of the minor allele; an increase indicates a detri-
mental effect on hearing function.
Two SNPs in the analysis achieved near-significance at
the sample-wide level: rs12959910 in CTIF for the high
frequency PTA (p = 0.00079, β = 0.61 dB, 95 % CI: 0.26-
0.97) and rs10492452 in LCP1 for the low frequency
PTA (p = 0.00056, β = 0.45 dB, 95 % CI: 0.20-0.71)
(Table 4 and Additional file 1).
CTIF SNPs and analysis of high frequency hearing
function in ALSPAC children
In the analysis of high-frequency hearing function, eight
out of the top ten smallest p-values were from SNPs in
CTIF (Table 4). This finding, combined with the very
low p-value of rs12959910, prompted us to seek valid-
ation for the results with CTIF for high frequencies in
the G-EAR cohort. No other gene in either the non-
Table 3 Summary of the study SNPs from ALSPAC
Gene Chromosome Number of SNPs Number of LD Blocks
ACAA2 18 4 1
C18ORF32 18 1 1
CDH23 10 7 2
CTIF 18 111 31
DYM 18 51 5
ESPNL 2 5 2
FSCN2 17 1 1
HCN2 19 3 2
LCP1 13 18 3
MYO5B 18 114 15
PCDH15 10 210 32
SMAD7 18 13 6
XIRP2 2 39 17
Total 577 118
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Table 4 Effect sizes of SNPs with the lowest p-values from the analysis of ALSPAC children
10 most significant SNPs associated with high frequency hearing overall (max n = 4970)
SNP Chromosome Base Position Gene Effect Size (dB) p-value LD Block Minor allele MAF
rs12959910 18 46337861 CTIF 0.61 0.00079 19 G 0.11
rs8085434 18 46200968 CTIF 0.84 0.0024 8 C 0.05
rs8091955 18 46358907 CTIF 0.34 0.0036 22 G 0.45
rs1994559 18 46332358 CTIF 0.43 0.0043 19 A 0.17
rs1319946 18 46359024 CTIF 0.31 0.0067 22 C 0.49
rs1877192 2 167863420 XIRP2 0.43 0.014 3 C 0.12
rs10825335 10 56234349 PCDH15 0.41 0.022 18 A 0.11
rs1317625 18 46380182 CTIF 0.3 0.026 25 A 0.22
rs7233521 18 46219733 CTIF 0.43 0.031 11 A 0.09
rs1316826 18 46348156 CTIF 0.26 0.032 18 C 0.31
10 most significant SNPs associated with high frequency hearing in males (max n = 2445)
SNP Chromosome Base Position Gene Effect Size (dB) p-value LD Block Minor allele MAF
rs2337069 18 46120940 CTIF 0.58 0.0041 3 T 0.22
rs16951446 18 47599093 MYO5B −1.06 0.0047 8 G 0.05
rs16951488 18 47610821 MYO5B −1.06 0.0047 8 G 0.05
rs8085434 18 46200968 CTIF 1.04 0.0093 8 C 0.05
rs10823837 10 73498910 CDH23 0.44 0.0094 1 C 0.43
rs1877192 2 167863420 XIRP2 0.65 0.011 3 C 0.12
rs11662494 18 46241017 CTIF −0.57 0.012 13 T 0.15
rs10825335 10 56234349 PCDH15 0.67 0.012 18 A 0.11
rs869000 2 167862974 XIRP2 0.74 0.019 3 C 0.07
rs4939612 18 47541612 MYO5B 0.52 0.022 7 T 0.16
10 most significant SNPs associated with high frequency hearing in females (max n = 2525)
SNP Chromosome Base Position Gene Effect Size (dB) p-value LD Block Minor allele MAF
rs4592338 10 56098424 PCDH15 1.21 0.0027 16 A 0.04
rs978674 10 56119975 PCDH15 1.17 0.0032 16 A 0.04
rs7321994 13 46742539 LCP1 −0.53 0.0055 2 A 0.20
rs1787534 18 47445407 MYO5B 0.75 0.0055 1 T 0.09
rs873816 18 46101074 CTIF −0.59 0.0079 2 C 0.15
rs9567638 13 46754734 LCP1 −1.43 0.0084 3 C 0.02
rs8087713 18 46677185 DYM 0.54 0.011 2 G 0.17
rs10775489 18 46667299 DYM 0.54 0.011 2 A 0.17
rs12959910 18 46337861 CTIF 0.64 0.012 19 G 0.10
rs2296119 13 46729259 LCP1 −0.49 0.015 2 T 0.17
10 most significant SNPs associated with low frequency hearing overall (max n = 4970)
SNP Chromosome Base Position Gene Effect Size (dB) p-value LD Block Minor allele MAF
rs10492452 13 46721562 LCP1 0.45 0.00056 1 A 0.20
rs16951446 18 47599093 MYO5B −0.73 0.0017 1 G 0.05
rs16951488 18 47610821 MYO5B −0.73 0.0017 1 G 0.05
rs16913796 10 55659824 PCDH15 −0.59 0.003 3 T 0.08
rs6561296 13 46702401 LCP1 0.38 0.0033 1 C 0.21
rs9316187 13 46713702 LCP1 0.33 0.0079 1 A 0.24
rs6432974 2 167982976 XIRP2 0.39 0.0097 5 T 0.14
rs1937389 10 56319852 PCDH15 0.37 0.01 24 G 0.16
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stratified or the subgroup analyses warranted further in-
vestigation from the analysis of high-frequency hearing
function (Additional file 1).
Examination of CTIF SNPs and high frequency hearing
function in the G-EAR adult cohort
To our knowledge, a GWAS of hearing function in chil-
dren has not been conducted. Therefore, we attempted
validation of our findings from ALSPAC within the G-
EAR cohort of adults over 18 years of age in isolated
European populations, which had been designed to as-
sess the hearing function and thresholds of isolated
European populations within the international G-EAR
consortium [17]. The 10 lowest p-values from the
ALSPAC results for SNPs in CTIF are reported in Table 5
with the corresponding p-value from G-EAR. No SNP
was found to have a clear effect in either the non-
stratified or the sub-group analyses. The low p-value of
rs12959910 was not replicated in the G-EAR cohort
(p = 0.11).
CTIF SNPs and analysis of otoacoustic emissions data
from ALSPAC children and in the G-EAR cohort
From the 13 genes examined, only one SNP, rs7233521
in CTIF, showed a relationship with broadband OAE in
the non-stratified and sub-group analyses of the
ALSPAC cohort. The effect was specific to females and
correlated with smaller amplitude OAE, i.e., poorer hear-
ing function (females, p = 0.00000037, β = −1.64 dB,
95 % CI: −2.27 to −1.01; males, p = 0.46, β = 0.22 dB,
95 % CI: −0.36-0.80) (see Additional file 1 for OAE
results). Notably, this SNP had the lowest p-value in
females for low frequency hearing function (Table 4). No
other SNP in CTIF had an effect on low frequency hear-
ing in the ALSPAC cohort. However, in G-EAR, a pos-
sible sex-specific effect of rs7233521 on high frequency
Table 4 Effect sizes of SNPs with the lowest p-values from the analysis of ALSPAC children (Continued)
rs11003924 10 55662156 PCDH15 −0.44 0.01 4 T 0.11
rs11003925 10 55662226 PCDH15 −0.44 0.01 4 T 0.11
10 most significant SNPs associated with low frequency hearing in males (max n = 2445)
SNP Chromosome Base Position Gene Effect Size (dB) p-value LD Block Minor allele MAF
rs1877192 2 167863420 XIRP2 0.69 0.0017 3 C 0.12
rs12571150 10 56546055 PCDH15 −0.51 0.0022 29 T 0.25
rs16951446 18 47599093 MYO5B −0.89 0.0062 1 G 0.05
rs16951488 18 47610821 MYO5B −0.89 0.0062 1 G 0.05
rs1912985 10 56538759 PCDH15 0.53 0.0068 28 T 0.16
rs10492452 13 46721562 LCP1 0.48 0.008 1 A 0.20
rs1317355 18 46379626 CTIF 0.45 0.0086 24 T 0.23
rs877885 18 46241163 CTIF 0.42 0.0097 13 A 0.26
rs11662494 18 46241017 CTIF −0.51 0.0098 13 T 0.15
rs937023 18 46383785 CTIF 0.41 0.011 25 C 0.28
10 most significant SNPs associated with low frequency hearing in females (max n = 2525)
SNP Chromosome Base Position Gene Effect Size (dB) p-value LD Block Minor allele MAF
rs7233521 18 46219733 CTIF 0.98 0.00047 11 A 0.09
rs9567638 13 46754734 LCP1 −1.76 0.0011 3 C 0.02
rs7321994 13 46742539 LCP1 −0.55 0.0039 2 A 0.20
rs11003876 10 55594049 PCDH15 0.45 0.004 1 C 0.43
rs11003889 10 55623229 PCDH15 0.49 0.0057 1 C 0.27
rs1937389 10 56319852 PCDH15 0.58 0.006 24 G 0.16
rs2296119 13 46729259 LCP1 −0.55 0.0062 2 T 0.17
rs4478893 10 55635024 PCDH15 0.43 0.0087 2 G 0.34
rs1900425 10 55638740 PCDH15 0.42 0.0093 3 A 0.34
rs8087713 18 46677185 DYM 0.54 0.01 2 G 0.17
LD block refers to the numbered LD blocks that were calculated using a solid spine of LD in Haploview. Effect size is reported per copy of minor allele in the SNP,
and represents the number of decibels (dB) higher or lower for the hearing threshold of children with the minor allele. A positive effect size represents a
decreased hearing threshold and a negative effect size represents enhanced hearing. Some SNPs are below the maximum n because not all SNPs in our study
were generated for each child. MAF =minor allele frequency
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Table 5 Effect sizes of SNPs in CTIF or LCP1 for averaged high or low frequency hearing compared between ALSPAC and G-EAR
CTIF: 10 most significant SNPs in high frequency tests overall
SNP Minor Allele Major allele ALSPAC MAF ALSPAC Effect Size (dB) ALSPAC p-value G-EAR Effect Size
(rank normal)
G-EAR p-value LD Block
rs12959910 G A 0.11 0.61 0.0008 0.096 0.11 19
rs8085434 C T 0.05 0.84 0.002 0.081 0.27 8
rs8091955 G A 0.45 0.34 0.004 0.045 0.22 22
rs1994559 A G 0.17 0.43 0.004 0.059 0.23 19
rs1319946 C T 0.49 0.31 0.007 0.040 0.24 22
rs1317625 A G 0.22 0.30 0.026 −0.021 0.59 25
rs7233521 A G 0.09 0.43 0.031 0.069 0.35 11
rs1316826 C T 0.31 0.26 0.032 0.059 0.17 21
rs4583322 A G 0.35 0.25 0.032 0.008 0.82 19
rs937021 G A 0.44 0.23 0.039 −0.043 0.21 25
CTIF: 10 most significant SNPs in high frequency tests in males
SNP Minor Allele Major allele ALSPAC MAF ALSPAC Effect Size (dB) ALSPAC p-value G-EAR Effect Size
(rank normal)
G-EAR p-value LD Block
rs2337069 T C 0.22 0.58 0.004 0.010 0.26 3
rs8085434 C T 0.05 1.04 0.009 0.002 0.89 8
rs11662494 T C 0.15 −0.57 0.012 0.001 0.91 13
rs937021 G A 0.45 0.37 0.026 0.003 0.74 25
rs12959910 G A 0.11 0.57 0.030 0.021 0.10 19
rs7227797 G A 0.31 0.38 0.033 0.014 0.07 3
rs1994559 A G 0.18 0.44 0.040 0.002 0.82 19
rs11082695 A G 0.17 −0.43 0.048 0.001 0.95 13
rs8091955 G A 0.46 0.32 0.058 0.014 0.08 22
rs1319946 C T 0.50 0.32 0.060 0.009 0.20 22
CTIF: 10 most significant SNPs in high frequency tests in females
SNP Minor Allele Major allele ALSPAC MAF ALSPAC Effect Size (dB) ALSPAC p-value G-EAR Effect Size
(rank normal)
G-EAR p-value LD Block
rs873816 C T 0.15 −0.59 0.008 −0.003 0.69 2
rs12959910 G A 0.10 0.64 0.012 −0.007 0.55 19
rs8091955 G A 0.45 0.33 0.036 0.001 0.86 22
rs4939781 G A 0.21 −0.40 0.040 −0.009 0.20 2
rs11082698 G A 0.46 0.32 0.043 −0.008 0.18 14
rs1317625 A G 0.21 0.38 0.047 −0.001 0.83 25
rs4939804 A G 0.23 0.36 0.053 −0.004 0.60 14
rs11662760 A G 0.09 −0.53 0.056 −0.006 0.58 1
rs7233521 A G 0.09 0.54 0.058 −0.028 0.04 11
rs1319946 C T 0.49 0.30 0.062 −0.001 0.90 22
LCP1: 10 most significant SNPs in low frequency tests overall
SNP Minor Allele Major allele ALSPAC MAF ALSPAC Effect Size (dB) ALSPAC p-value G-EAR Effect Size
(rank normal)
G-EAR p-value LD Block
rs10492452 A C 0.20 0.45 0.0006 −0.009 0.86 1
rs6561296 C T 0.21 0.38 0.003 −0.013 0.79 1
rs9316187 A G 0.24 0.33 0.008 0.007 0.87 1
rs1409437 G A 0.44 −0.23 0.029 −0.066 0.08 1
rs2146880 A C 0.45 0.23 0.030 0.025 0.52 1
Harrison et al. BMC Medical Genomics  (2015) 8:48 Page 8 of 13
hearing was noted (p = 0.04 in females, p = 0.32 in males)
(Additional file 1).
LCP1 SNPs and analysis of low frequency hearing function
in ALSPAC children
In the non-stratified analysis of low frequency hearing
for the ALSPAC children, 3 of the 10 lowest p-values
were from SNPs in the LCP1 gene, including the SNP
with the lowest p-value in our analysis, rs10492452
(p = 0.00056, β = 0.45 dB, 95 % CI: 0.20-0.71) (Table 4).
Furthermore, LCP1 seemed to have some gender spe-
cificity, as the LCP1 SNP with the largest effect size,
rs9567638, had a negative, (i.e., enhanced hearing), effect
in girls (p = 0.0011, β = −1.76 dB, 95 % CI: −2.81 to −0.71)
(Table 4) but a positive (i.e., reduced hearing) or null effect
in boys (p = 0.23, β = 0.61 dB, 95 % CI: −0.41-1.6, likeli-
hood ratio test p = 0.006). There were no differences in
the proportion of minor (SNP) alleles between the genders
(Tables 4 and 5). No other gene warranted further investi-
gation in either the overall or the subgroup analyses of the
low frequency hearing data in ALSPAC children.
Examination of LCP1 SNPs and low frequency hearing
function in the G-EAR adult cohort
Given that only 3 % of the SNPs (18/577) under investi-
gation are in LCP1, the above possible association
Table 5 Effect sizes of SNPs in CTIF or LCP1 for averaged high or low frequency hearing compared between ALSPAC and G-EAR
(Continued)
rs1886040 C T 0.49 0.22 0.039 0.028 0.47 1
rs2093707 A C 0.49 0.21 0.046 0.034 0.37 1
rs7321994 A G 0.20 −0.24 0.067 −0.047 0.25 2
rs2209093 C T 0.17 −0.25 0.074 −0.071 0.09 2
rs2296119 T C 0.17 −0.25 0.076 −0.032 0.46 2
LCP1: 10 most significant SNPs in low frequency tests in males
SNP Minor Allele Major allele ALSPAC MAF ALSPAC Effect Size (dB) ALSPAC p-value G-EAR Effect Size
(rank normal)
G-EAR p-value LD Block
rs10492452 A C 0.20 0.48 0.008 −0.004 0.67 1
rs6561296 C T 0.21 0.40 0.026 −0.006 0.48 1
rs9316187 A G 0.24 0.37 0.031 −0.004 0.63 1
rs1409437 G A 0.44 −0.30 0.039 0.003 0.60 1
rs2146880 A C 0.45 0.26 0.072 −0.001 0.89 1
rs1886040 C T 0.49 0.26 0.075 −0.003 0.56 1
rs2093707 A C 0.49 0.25 0.081 −0.003 0.66 1
rs17601960 C T 0.08 −0.36 0.168 0.043 0.01 3
rs9567638 C T 0.02 0.59 0.246 0.024 0.48 3
rs10492449 G T 0.33 0.14 0.373 −0.006 0.33 3
LCP1: 10 most significant SNPs in low frequency tests in females
SNP Minor Allele Major allele ALSPAC MAF ALSPAC Effect Size (dB) ALSPAC p-value G-EAR Effect Size
(rank normal)
G-EAR p-value LD Block
rs9567638 C T 0.02 −1.76 0.0011 0.021 0.53 3
rs7321994 A G 0.20 −0.55 0.004 0.006 0.19 2
rs2296119 T C 0.17 −0.55 0.006 0.005 0.35 2
rs2209093 C T 0.17 −0.50 0.012 0.005 0.27 2
rs10492452 A C 0.21 0.43 0.026 0.003 0.64 1
rs2209092 G A 0.22 −0.37 0.042 0.006 0.17 2
rs6561296 C T 0.22 0.36 0.056 0.004 0.55 1
rs9316187 A G 0.24 0.29 0.110 0.007 0.25 1
rs2146880 A C 0.45 0.20 0.202 0.000 0.97 1
rs1886040 C T 0.49 0.18 0.247 0.003 0.55 1
LD block refers to the numbered LD blocks that were calculated using a solid spine of LD in Haploview. The effect allele in G-EAR was the same as in ALSPAC, but
the effect sizes in G-EAR were calculated using a rank normal transformation (see Methods) and so cannot be compared directly with the effect sizes from ALSPAC.
MAF =minor allele frequency in ALSPAC
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prompted us to attempt to validate the LCP1 results for
low frequency hearing against the G-EAR cohort. A
notable result was obtained from the female subjects in
G-EAR: rs17601960 in LCP1 had a large, sex-specific
effect for averaged low frequencies of hearing. These
included 0.125 kHz, a frequency that was not studied in
ALSPAC (p = 0.0008432, see Additional file 1). This SNP
is in the same LD group as rs9567638, which correlated
with a large effect on low hearing frequencies in girls in
ALSPAC (Table 4). Both SNPs have low minor allele fre-
quencies (rs9567638 = 0.02, rs17601960 = 0.036), and re-
duce (i.e., improve) the low frequency hearing threshold.
No other results were replicated in G-EAR (Table 5).
Genomic loci of identified SNPs of interest in CTIF and LCP1
The genomic loci of the SNPs of most interest from
CTIF and LCP1 were identified in dbSNP and examined
with regard to the human genome reference assembly.
All five SNPs of interest: rs12959910 and rs7233521 in
CTIF and rs10492452, rs17601960 and rs9567638 in
LCP1, are intronic variants. The two SNPs in CTIF have
distinct locations within the gene (Fig. 1a). Interestingly,
rs17601960 and rs9567638 in LCP1, which are in the
same LD group, are located in the same large intron.
SNP rs10492452 has a distinct location in intron 12–13
(Fig. 1b).
Discussion
This study demonstrates for the first time that SNPs in
CTIF and LCP1 correlate with effects on hearing func-
tion in children at age 11. No individual SNP achieved
our a priori overall sample-wide significance threshold,
despite the size of the sample studied, although single
SNPs from LCP1 and CTIF came close to this threshold.
External validation against an adult population did not
confirm a general involvement of CTIF or LCP1 in hear-
ing function in adults. However, there was evidence of
many SNPs in CTIF being detrimental to high frequency
hearing in children, and evidence of a specific LD block
in LCP1 being correlated with enhanced low frequency
hearing in girls and adult women. No effect was ob-
served on otoacoustic emissions, except for SNP
rs7233521 in CTIF in females; this SNP had the lowest
p-value for low frequency hearing results in ALSPAC.
This SNP was not validated in the analysis of data from
G-EAR. Nevertheless, given the extremely low p-value
obtained in the ALSPAC cohort, this SNP may be a
worthwhile target for future research.
In mice, Ctif is within the interval of ahl9, a quantita-
tive trait locus correlated with early-onset, low frequency
(4 kHz) hearing loss in BXD recombinant inbred mice
[15]: mice hear between 1 to 70 kHz, whereas humans
hear between 20 Hz to 20 kHz. So 4 kHz is “low fre-
quency” for mice but not for humans. Ctif was demon-
strated to be expressed in the mouse cochlea with an
expression level that is influenced by the parental allele,
but the exact sites of expression have yet to be estab-
lished [15]. The CTIF protein is peri-nuclear and is
expressed in many cell types. It is a component of the
CBP80/20 translation initiation complex that has a role
in nonsense-mediated mRNA decay [33]. Thus, alter-
ations in CTIF levels or functionality could potentially
LCP1: chromosome 13B
rs10492452
CTIF: chromosome 18A
Fig. 1 Genomic loci of SNPs in CTIF and LCP1 found to correlate with altered hearing function in children and/or adult women. a, diagram of
CTIF with the positions of implicated SNPs marked. b, diagram of LCP1 with the positions of implicated SNPs marked
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affect many target mRNAs. Further research will be
needed to establish the expression patterns and func-
tional significance of CTIF in the inner ear.
The protein product of LCP1, designated plastin-2 or
L-plastin, is a member of the plastin family of actin-
binding proteins. The mammalian family also includes
plastin-1, also known as I-plastin or fimbrin, which is
highly expressed in intestine and kidney, and plastin-3
or T-plastin, which is expressed in most solid tissues
[34, 35]. Plastin-2 has been characterised principally
as a protein present in cells of haematopoietic line-
ages. In leukocytes, plastin-2 interacts with LFA-1 in-
tegrin and is important for leukocyte polarisation,
migration and innate and adaptive immune responses.
Lcp1−/− mice are viable but show defects in B cell
development and immune responses [36, 37]. Up-
regulation of plastin-2 occurs in various human can-
cers and a coding SNP in LCP1 has been correlated
with gender- and tumour-stage specific prognostic
significance in colorectal cancer recurrence [38, 39].
There are multiple reports that plastin-1 and plastin-
3 are present in hair cells; specifically, in the F-actin bun-
dles of stereocilia. Whereas plastin-1 is present in mature
stereocilia, plastin-3 has been detected transiently in rat
cochlea during hair cell differentiation [40–42]. Subse-
quent proteomics of hair bundles purified from chicken
utricles demonstrated that plastin-1 and fascin-2 are the
most abundant cross-linking proteins in these bundles; in
addition, both plastin-2 and plastin-3 are present in low
abundance [13, 32]. To our knowledge, these are the
only data on plastin-2 in hair cells. Recently, plastin-1
(Pls1) gene knockout mice were found to have mod-
erate, progressive hearing loss across all frequencies
that correlated with morphological abnormalities of
stereocilia in mature hair cells [43]. Investigations of
Lcp1 gene knockout mice have focused on immuno-
logical functions.
In our study, the SNPs in LCP1 appeared to be sex-
specific, were protective and had low minor allele fre-
quencies, which could possibly represent a relatively
new set of mutations. Because these are intronic
SNPs, it is possible that their effects relate to mRNA
stability. It would be helpful to conduct audiometry
testing on Lcp1 knockout mice to determine if there
is a causal relationship between Lcp1 and hearing
function.
CTIF had an influence on high frequency but not low
frequency hearing, whereas LCP1 affected only low fre-
quency hearing; these differential frequency effects will
require further investigation. It is interesting that the
associations were observed with audiometry but not with
otoacoustic emissions. Otoacoustic emissions are sen-
sitive to the cochlear amplification function of the
outer hair cells [44]. In this study, the lack of an
association with OAEs implies that there is no meas-
urable effect of the genes studied on outer hair cell
cochlear amplification processes, with the possible ex-
ception of rs7233521 in CTIF in females.
CDH23 or PCDH15 were included in our study set of
genes due to their known causal roles in inherited forms
of deafness [1, 3, 24]. Whereas SNPs in PCDH15 were
amongst those with the lowest p values for effects on
high or low frequency hearing in ALSPAC (Table 4), no
SNPs were returned from CDH23. This is likely because
only a small number of CDH23 SNPs have been geno-
typed in ALSPAC. In comparison to CTIF, the other
candidate genes examined from the syntenic region of
human chromosome 18, ACAA2, C18orf32, DYM,
MYO5B and SMAD7 (Table 1), did not show effects on
hearing, although this could be explained by limitations
in the study. The causes of sensorineural hearing loss
are not known for individual children in ALSPAC; in-
deed, this is expected given that ALSPAC is a population
study. To date, two genes known to be associated with
hearing loss have been specifically examined within the
cohort. The most common genetic cause of sensori-
neural hearing loss is the 35delG mutation of GJB2,
which encodes the gap junction protein, connexin 26.
No children with genotypic data within the cohort are
homozygous for 35delG [16]. Also, none of the children
in the cohort with the known mitochondrial DNA muta-
tion 1555A- > G have hearing loss [45].
The major strengths of this study are the large number
of children with accurate audiometry tests and full geno-
typic data, resulting in precise associations between
SNPs and phenotype. To our knowledge, this is one of
few studies to assess genetic contributions to hearing
variation in children.
Several limitations are recognised. Due to the genotyp-
ing chip used, some of the selected genes were poorly
represented by SNPs in ALSPAC to draw information
from (e.g., FSCN-2, 1 SNP; HCN2, 3 SNPs; ESPNL, 5
SNPs; CDH23, 7 SNPs). Due to the above-mentioned
scarcity of genome-wide association studies that have ex-
amined hearing in children, replication of our results
could not be attempted in a dataset that tested children.
The G-EAR dataset used for replication comprised
adults with varying degrees of hearing loss, likely to be
caused by age and environmental effects. The ALSPAC
cohort at age 11 mostly had hearing thresholds within
the normal range. The effect sizes of the G-EAR dataset
could not be compared to ALSPAC due to differences in
analysis methods. It is possible that effects on hearing of
other genes studied were not detected due to: small
effect sizes; the effect appearing after 11 years of age; the
demographics of our study; or that functionally import-
ant regions of the genes were not covered by the SNPs
examined.
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Conclusions
This study demonstrates, for the first time, suggestive
associations of SNPs in CTIF and LCP1 with effects on
hearing function in children at age 11. Although these
findings were not validated against an independent adult
population, there was evidence of a sex-specific locus in
LCP1 being correlated with enhanced low frequency
hearing function in girls and adult women. Further stud-
ies of CTIF and LCP1 in relation to hearing function and
hair cell physiology would be warranted.
Additional file
Additional file 1: Results for all the SNPs included in the analyses
of data from ALSPAC or G-EAR.
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